Oak Thistle LLC Makes New Investment in HCA Healthcare, Inc. $HCA

Oak Thistle LLC purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 4,736 shares of the company’s stock, valued at approximately $2,211,000.

Several other hedge funds have also added to or reduced their stakes in the business. Sovran Advisors LLC lifted its stake in HCA Healthcare by 1.0% in the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock worth $1,063,000 after purchasing an additional 22 shares during the last quarter. Centerpoint Advisors LLC raised its stake in shares of HCA Healthcare by 11.0% during the third quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock valued at $95,000 after acquiring an additional 22 shares during the last quarter. Cary Street Partners Financial LLC raised its stake in shares of HCA Healthcare by 3.9% during the third quarter. Cary Street Partners Financial LLC now owns 590 shares of the company’s stock valued at $251,000 after acquiring an additional 22 shares during the last quarter. Angeles Wealth Management LLC raised its stake in shares of HCA Healthcare by 2.4% during the third quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock valued at $432,000 after acquiring an additional 24 shares during the last quarter. Finally, One Capital Management LLC raised its stake in shares of HCA Healthcare by 1.1% during the third quarter. One Capital Management LLC now owns 2,250 shares of the company’s stock valued at $959,000 after acquiring an additional 24 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on HCA. The Goldman Sachs Group upped their price objective on shares of HCA Healthcare from $520.00 to $558.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Morgan Stanley downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective for the company. in a research note on Monday, December 15th. JPMorgan Chase & Co. increased their price target on shares of HCA Healthcare from $420.00 to $535.00 and gave the stock a “neutral” rating in a research note on Friday, February 20th. Barclays increased their price target on shares of HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 28th. Finally, Royal Bank Of Canada raised their price objective on HCA Healthcare from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $537.73.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total value of $2,020,000.00. Following the transaction, the senior vice president directly owned 44,379 shares in the company, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the transaction, the senior vice president owned 11,993 shares in the company, valued at $6,171,357.94. The trade was a 40.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 15,214 shares of company stock valued at $7,797,595 over the last three months. Insiders own 1.50% of the company’s stock.

HCA Healthcare Stock Up 1.0%

Shares of HCA opened at $488.74 on Wednesday. HCA Healthcare, Inc. has a twelve month low of $314.43 and a twelve month high of $556.52. The firm has a 50 day moving average of $511.03 and a 200 day moving average of $480.20. The company has a market capitalization of $109.27 billion, a P/E ratio of 17.22, a price-to-earnings-growth ratio of 1.45 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter last year, the company posted $6.22 earnings per share. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th were issued a $0.78 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date was Tuesday, March 17th. HCA Healthcare’s dividend payout ratio is 10.99%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.